About this trial
This study investigates whether alteplase can help to improve pleural fluid drainage and dyspnea (breathlessness) in patients with non-draining malignant pleural effusion. Alteplase helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. Alteplase may help to control symptoms of breathlessness.
Eligibility criteria
Qualifiers
Referral to pulmonary services for inability to drain fully via IPC
Presence of a symptomatic septated pleural effusion
Chest radiograph: effusion filling >= 1/3 of the hemithorax, or
Computed tomography (CT)-scan: AP depth of the effusion >= 1/3 of the AP dimension on the axial image superior to the hemidiaphragm, including atelectatic lung surrounded by effusion, or
Disqualifiers
Inability to provide informed consent
Uncorrectable coagulopathy based on criteria followed by cardiopulmonary center for procedures.
Active bleeding
Known allergic reaction to thrombolytics
Trial design
Treatments tested in this trial
- Alteplase
- Placebo Administration
Treatment groups
Locations
1Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor